Looking ahead to 2030, our model projects BNTX could trade at an average price of $228.44, with a potential range between $171.33 and $285.55. This represents a potential 153.2% return from today's ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in BioNTech’s Covid-19 vaccine and in BNTX stock. Meanwhile, BioNTech has ...

Fintel reports that on November 10, 2025, HC Wainwright & Co. maintained coverage of BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) with a Buy recommendation. As of November 9, 2025, the average one ...

We came across a bullish thesis on BioNTech SE on Memyselfandi007’s Substack. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE’s share was trading at $103.80 as of March 4th.

BioNTech (BNTX) stock was under pressure on May 5 after the multinational announced plans to eliminate up to 1,860 roles as it continues to grapple with declining COVID-19 vaccine sales. The selloff ...

BioNTech SE is transitioning from a COVID-19 vaccine story to a late-stage oncology platform with a robust $17B cash position. At a $27.6B market cap and ~$11B enterprise value, BNTX's ...

Bank of America upgraded BioNTech (NASDAQ:BNTX) on Thursday, citing the prospects of the company’s oncology franchise after its rival Moderna (MRNA) shared mid-stage data for its personalized mRNA ...

BioNTech SE Sponsored ADR (BNTX) shares rallied 11.8% in the last trading session to close at $118. This move can be attributable to notable volume with a higher number of shares being traded than in ...

Is BNTX a good stock to buy? We came across a bullish thesis on BioNTech SE on r/ValueInvesting by birdflustocks. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE’s share was ...